Long-Term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis - Results of an Open-Label Extension Study

被引：0
|
作者：
Feist, Eugen [1 ]
Nasonov, Evgeny [2 ]
Luggen, Michael [3 ]
Fatenejad, Saeed [4 ]
Grishin, Sergey [5 ]
Samsonov, Mikhail [6 ]
Fleischmann, Roy [7 ,8 ]
机构：
[1] Otto von Guericke Univ, Helios Clin VogelsangGommern, Magdeburg, Germany
[2] VA Nasonova Res Inst Rheumatol, Moscow, Russia
[3] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[4] SFC Med LLC, Charlotte, NC USA
[5] R Pharm, Moscow, Russia
[6] R Pharm JSC, Moscow, Russia
[7] Univ Texas SouthWestern Med Ctr, Dallas, TX USA
[8] Metroplex Clin Res Ctr, Dallas, TX USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0309
引用
收藏
页码：603 / 606
页数：4
相关论文
共 50 条
  • [31] Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study
    Nash, Peter
    Coates, Laura C.
    Kivitz, Alan
    Mease, Philip J.
    Gladman, Dafna D.
    Covarrubias-Cobos, Jose A.
    Fitzgerald, Oliver
    Fleishaker, Dona
    Wang, Cunshan
    Wu, Joseph
    Hsu, Ming-Ann
    Menon, Sujatha
    Fallon, Lara
    Romero, Ana Belen
    Kanik, Keith S.
    RHEUMATOLOGY AND THERAPY, 2020, 7 (03) : 553 - 580
  • [32] Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study
    Peter Nash
    Laura C. Coates
    Alan J. Kivitz
    Philip J. Mease
    Dafna D. Gladman
    José A. Covarrubias-Cobos
    Oliver FitzGerald
    Dona Fleishaker
    Cunshan Wang
    Joseph Wu
    Ming-Ann Hsu
    Sujatha Menon
    Lara Fallon
    Ana Belén Romero
    Keith S. Kanik
    Rheumatology and Therapy, 2020, 7 : 553 - 580
  • [33] CLINICAL OUTCOMES OF RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB MONOTHERAPY IN THE OPEN-LABEL LONG-TERM EXTENSION
    Fleischmann, R.
    Wollenhaupt, J.
    Wang, L.
    Maniccia, A.
    Kwok, K.
    Takiya, L.
    van Vollenhoven, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 259 - 260
  • [34] Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial
    Grossman, J
    Smith, LJ
    Wilson, AM
    Thyrum, PT
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (04) : 361 - 369
  • [35] LONG-TERM SAFETY AND EFFICACY OF DUPILUMAB IN PATIENTS WITH ASTHMA: LIBERTY ASTHMA TRAVERSE OPEN-LABEL EXTENSION STUDY
    Pavord, Id
    Wechsler, Me
    Domingo, C.
    Papi, A.
    Bourdin, A.
    Watz, H.
    Mao, X.
    Kapoor, U.
    Khokhar, Fa
    Mannent, Lp
    Ruddy, M.
    Laws, E.
    Amin, N.
    Hardin, M.
    THORAX, 2021, 76 : A81 - A82
  • [36] LONG-TERM EFFICACY OF LANADELUMAB: INTERIM RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
    Riedl, M.
    Cicardi, M.
    Hao, J.
    Lu, P.
    Li, H.
    Manning, M.
    Bernstein, J.
    Busse, P.
    Tachdjian, R.
    Gower, R.
    Wedner, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S30 - S31
  • [37] Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study)
    Partinen, Markku
    Hirvonen, Kari
    Jama, Leni
    Alakuijala, Anniina
    Hublin, Christer
    Tamminen, Ilkka
    Koester, Juergen
    Reess, Juergen
    SLEEP MEDICINE, 2008, 9 (05) : 537 - 541
  • [38] Long-term safety and efficacy of clobazam for Lennox-Gastaut syndrome: Interim results of an open-label extension study
    Ng, Yu-Tze
    Conry, Joan
    Paolicchi, Juliann
    Kernitsky, Lydia
    Mitchell, Wendy
    Drummond, Rebecca
    Isojarvi, Jouko
    Lee, Deborah
    Owen, Randall
    EPILEPSY & BEHAVIOR, 2012, 25 (04) : 687 - 694
  • [39] Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study
    Goemans, Nathalie M.
    Tulinius, Mar
    van den Hauwe, Marleen
    Kroksmark, Anna-Karin
    Buyse, Gunnar
    Wilson, Rosamund J.
    van Deutekom, Judith C.
    de Kimpe, Sjef J.
    Lourbakos, Afrodite
    Campion, Giles
    PLOS ONE, 2016, 11 (09):
  • [40] Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: results from the DAYBREAK open-label extension study
    Steinman, L.
    Comi, G.
    Bar-Or, A.
    Selmaj, K. W.
    Arnold, D. L.
    Hartung, H. -P.
    Montalban, X.
    Havrdova, E. K.
    Sheffield, J. K.
    Minton, N.
    Janjua, A.
    Huang, V.
    Silva, D.
    Kappos, L.
    Cohen, J. A.
    Cree, B. A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 548 - 549
12345